TheraCryf partners with Pharmaron to develop addiction programme
(Alliance News) - TheraCryf PLC on Monday said it has signed a master service agreement with Pharmaron UK Ltd to progress development of its Orexin-1 addiction programme. Read More
Price | 0.235p on 12-05-2025 | at 17:10:12
---|---|
Change | 0.00p 0% |
Buy | 0.27p |
Sell | 0.20p |
Buy / Sell TCF Shares |
Last Trade: | Buy 33,311.00 at 0.265p |
Day's Volume: | 490,880 |
Last Close: | 0.235p |
Open: | 0.235p |
ISIN: | GB00BSVYN304 |
Day's Range | 0.235p - 0.235p |
52wk Range: | 0.204p - 1.22p |
Market Capitalisation: | £5m |
VWAP: | 0.229183p |
Shares in Issue: | 2,130m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 33,311 | 0.265p | Suspected BUY Trade |
14:00:24 - 12-May-25 |
Buy* | 33,311 | 0.265p | Ordinary |
13:59:59 - 12-May-25 |
Sell* | 400,000 | 0.221p | Ordinary |
13:19:13 - 12-May-25 |
Buy* | 21,485 | 0.2658p | Ordinary |
10:49:12 - 12-May-25 |
Sell* | 181 | 0.20p | Ordinary |
08:43:04 - 12-May-25 |
Sell* | 5,000 | 0.23p | Ordinary |
14:24:12 - 09-May-25 |
Sell* | 109,301 | 0.23p | Ordinary |
13:29:41 - 09-May-25 |
Buy* | 1,511,364 | 0.264p | Ordinary |
09:30:09 - 09-May-25 |
Buy* | 3,703 | 0.27p | Ordinary |
08:35:11 - 09-May-25 |
Buy* | 111,111 | 0.264p | Ordinary |
08:08:12 - 09-May-25 |
Theracryf PLC (TCF) Regulatory News |
||
Date | Source | Headline |
---|---|---|
1st May 2025 7:00 am | RNS | Board Appointment, Grant of Options, PDMR Dealing |
26th Mar 2025 7:00 am | RNS-R | Investor webinar |
21st Mar 2025 3:55 pm | RNS | Holding(s) in Company |
20th Mar 2025 3:33 pm | RNS | Holding(s) in Company |
20th Mar 2025 11:01 am | RNS | Holding(s) in Company |
19th Mar 2025 12:10 pm | RNS | Holding(s) in Company |
17th Mar 2025 2:17 pm | RNS | Holding(s) in Company |
17th Mar 2025 7:00 am | RNS | Holding(s) in Company |
17th Mar 2025 7:00 am | RNS | Holding(s) in Company |
17th Mar 2025 7:00 am | RNS | Holding(s) in Company |